(813) 345-4044 | info@floridaaesthetics.com | Mon–Tue & Thu–Fri: 8am–5pm  ·  Wed: 10am–7pm | 1767 S. Kings Ave., Brandon, FL 33511
Weight Loss Tirzepatide at Florida Aesthetics Brandon FL

Weight Loss · Dual GIP/GLP-1 · Brandon, FL

Tirzepatide
Dual-Action Weight Loss Program

The most effective FDA-approved weight loss medication available, a dual GIP/GLP-1 receptor agonist showing up to 22% average body weight reduction in clinical trials. A step up from semaglutide for patients who want maximum results.

FDA-Approved
for weight management (Zepbound®)
Up to 22%
average body weight lost (SURMOUNT)
Weekly Injection
physician-supervised
About This Treatment

What is tirzepatide and how does it cause weight loss?

Tirzepatide (brand names Mounjaro® and Zepbound®) is the first dual GIP and GLP-1 receptor agonist, activating two hormonal pathways simultaneously to produce greater weight loss than GLP-1 medications alone.

GLP-1 receptor agonists like semaglutide reduce appetite and slow gastric emptying. Tirzepatide does all of that, and also activates GIP (glucose-dependent insulinotropic polypeptide) receptors, which enhances insulin secretion, reduces glucagon, and appears to amplify the total weight loss effect. In the SURMOUNT-1 clinical trial, participants on tirzepatide lost an average of 20.9% of body weight at the highest dose over 72 weeks, making it the most effective approved weight loss medication available. At Florida Aesthetics, all tirzepatide programs are physician-supervised with regular check-ins to monitor progress and adjust dosing.

Who is a candidate for tirzepatide?

  • Adults with BMI ≥30 (obesity)
  • Adults with BMI ≥27 with weight-related conditions (diabetes, hypertension, dyslipidemia)
  • Patients who want maximum weight loss results
  • Those who have plateaued on semaglutide
  • Insulin resistance and pre-diabetes
  • Diet-resistant weight

Why patients choose Florida Aesthetics for tirzepatide

  • Physician-prescribed and supervised, not a telehealth mill
  • Gradual titration starting at 2.5 mg to minimize GI side effects
  • Body composition monitoring to ensure fat loss, not muscle
  • Regular progress check-ins and dose adjustment
  • Can transition from semaglutide if plateauing
Transparent Pricing

How much does tirzepatide cost in Brandon, FL?

Tirzepatide is priced monthly. Costs vary based on dose. Most patients start at 2.5 mg and titrate up over 20 weeks. Ask about current pricing at your consultation.

Starter Dose

2.5 mg · Weeks 1–4

Ask at

consultation per month

  • 2.5 mg starting dose
  • Minimize GI side effects
  • Gradual titration protocol
Book Consultation

Bundle + B12/MIC

Best value

Ask at

consultation per month

  • Tirzepatide + weekly B12/MIC
  • Enhanced energy + fat metabolism
  • Most comprehensive program
Learn More
Tirzepatide weight loss experience
What to Expect

What to expect on your tirzepatide journey

1
Medical evaluation
Your provider reviews your health history, current medications, and weight loss goals. Lab work screens for contraindications (including thyroid history). A personalized dosing schedule is created starting at 2.5 mg weekly.
2
Starting at 2.5 mg
You begin at 2.5 mg weekly, the lowest dose, to minimize GI side effects. Most patients tolerate tirzepatide well after the first 2–4 weeks as the body adjusts.
3
Titration phase (weeks 4–20)
Dosing is gradually increased by 2.5 mg every 4 weeks toward your therapeutic target (up to 15 mg). Appetite reduction becomes pronounced. Most patients begin seeing 1–2 lbs per week loss during titration.
4
Maintenance and monitoring
Monthly check-ins track your progress, adjust dosing if needed, and provide ongoing support. We recommend pairing tirzepatide with body composition scans to ensure you're losing fat, not muscle, and to track your metabolic changes over time.
Common Questions

Tirzepatide Weight Loss, Frequently Asked Questions

The SURMOUNT-1 trial showed average weight loss of 20.9% at the 15 mg dose over 72 weeks. At 5 mg, average loss was 15%. Some participants lost more than 25% of body weight. Tirzepatide consistently outperformed semaglutide in comparative data. Individual results vary.
The most common side effects are GI-related: nausea, diarrhea, constipation, and reduced appetite. These typically improve after the first 4–8 weeks and are minimized by slow titration starting at 2.5 mg. Your provider screens for contraindications including personal or family history of thyroid cancer (MEN2) before prescribing.
In the SURMOUNT vs. STEP clinical data, tirzepatide produced greater average weight loss than semaglutide at comparable doses. Tirzepatide activates two hormone pathways (GIP + GLP-1) vs. one (GLP-1 alone), which appears to produce an additive effect. That said, the best medication is the one that works for your body, your provider will evaluate which is most appropriate.
Yes, tirzepatide is the active ingredient in both Mounjaro® (approved for type 2 diabetes) and Zepbound® (FDA-approved in November 2023 for chronic weight management). At Florida Aesthetics, we prescribe the weight management protocol.
Yes, many patients transition to tirzepatide after plateauing on semaglutide. Your provider will guide the transition with appropriate dosing. Tirzepatide also pairs well with B12/MIC injections (for energy and metabolism) and body composition analysis (to track fat vs. muscle changes).

Ready to Book?

Start with a free consultation, no obligation

Our physician will evaluate your health history and determine if tirzepatide is the right program for you. Schedule your complimentary consultation.